Cargando…

Serum Anti-Müllerian Hormone Levels in Patients with Epithelial Ovarian Cancer

Objectives. The aim of our study was to examine serum anti-Müllerian hormone (AMH) concentration in ovarian cancer patients in relation to clinicopathological features, such as a pathological subtype of the tumor, (FIGO) stage, grading, and overall 5-year survival. Material and Methods. We enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walentowicz, Pawel, Sadlecki, Pawel, Krintus, Magdalena, Sypniewska, Grazyna, Mankowska-Cyl, Aneta, Grabiec, Marek, Walentowicz-Sadlecka, Malgorzata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745840/ https://www.ncbi.nlm.nih.gov/pubmed/23983687 http://dx.doi.org/10.1155/2013/517239

Ejemplares similares

Serum Inhibin A and Inhibin B Levels in Epithelial Ovarian Cancer Patients
por: Walentowicz, Pawel, et al.
Publicado: (2014)

Serum 25(OH) Vitamin D Levels in Polish Women during Pregnancies Complicated by Hypertensive Disorders and Gestational Diabetes
por: Domaracki, Piotr, et al.
Publicado: (2016)

Why do patients decline amniocentesis? Analysis of factors influencing the decision to refuse invasive prenatal testing
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Prenatal Clinical Assessment of NT-proBNP as a Diagnostic Tool for Preeclampsia, Gestational Hypertension and Gestational Diabetes Mellitus
por: Sadlecki, Pawel, et al.
Publicado: (2016)

Broad ligament pregnancy – A rare and challenging diagnosis
por: Sadłecki, Paweł, et al.
Publicado: (2021)

Assessment of the SFlt-1 and sFlt-1/25(OH)D Ratio as a Diagnostic Tool in Gestational Hypertension (GH), Preeclampsia (PE), and Gestational Diabetes Mellitus (GDM)
por: Walentowicz-Sadlecka, Malgorzata, et al.
Publicado: (2019)

Human amniotic fluid as a source of stem cells
por: Walentowicz, Pawel, et al.
Publicado: (2022)

Expression of zinc finger transcription factors (ZNF143 and ZNF281) in serous borderline ovarian tumors and low-grade ovarian cancers
por: Sadłecki, Paweł, et al.
Publicado: (2019)

The Preoperative Maximum Standardized Uptake Value Measured by 18F-FDG PET/CT as an Independent Prognostic Factor of Overall Survival in Endometrial Cancer Patients
por: Walentowicz-Sadlecka, Malgorzata, et al.
Publicado: (2014)

The Role of Hypoxia-Inducible Factor-1α, Glucose Transporter-1, (GLUT-1) and Carbon Anhydrase IX in Endometrial Cancer Patients
por: Sadlecki, Pawel, et al.
Publicado: (2014)

Stromal Derived Factor-1 (SDF-1) and Its Receptors CXCR4 and CXCR7 in Endometrial Cancer Patients
por: Walentowicz-Sadlecka, Malgorzata, et al.
Publicado: (2014)

Prenatal diagnosis of fetal defects and its implications on the delivery mode
por: Sadlecki, Pawel, et al.
Publicado: (2023)

Expression of Selected Epithelial-Mesenchymal Transition Transcription Factors in Endometrial Cancer
por: Sadłecki, Paweł, et al.
Publicado: (2020)

Human Adipose-Derived and Amniotic Fluid-Derived Stem Cells: A Preliminary In Vitro Study Comparing Myogenic Differentiation Capability
por: Bajek, Anna, et al.
Publicado: (2018)

Chosen Vascular Risk Markers in Pseudoexfoliation Syndrome: An Age-Related Disorder
por: Lesiewska, Hanna, et al.
Publicado: (2017)

Gestational Diabetes Mellitus Worsens the Profile of Cardiometabolic Risk Markers and Decrease Indexes of Beta-Cell Function Independently of Insulin Resistance in Nondiabetic Women with a Parental History of Type 2 Diabetes
por: Sokup, Alina, et al.
Publicado: (2014)

Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology
por: Jarzabek, Katarzyna, et al.
Publicado: (2013)

Bilateral aggressive malignant granulosa cell tumour with essentially different immunophenotypes in primary and metastatic lesions comprising predominantly sarcomatoid and fibrothecomatous patterns – looking for prognostic markers: a case report
por: Jozwicki, Wojciech, et al.
Publicado: (2011)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

New Adipokines Linked to Obesity and Obesity-Related Diseases
por: Mankowska, Aneta, et al.
Publicado: (2006)

The Role of Matrix Metalloproteinase-3 In the Development of Atherosclerosis and Cardiovascular Events
por: Magdalena, Krintus, et al.
Publicado: (2006)

Adiponectin and Metabolic Syndrome in Women at Menopause
por: Mankowska, Aneta, et al.
Publicado: (2009)

Association of C-Reactive Protein and Other Markers of Inflammation with Risk of Complications in Diabetic Subjects
por: Mankowska, Aneta, et al.
Publicado: (2006)

Serum ANGPTL8 and ANGPTL3 as Predictors of Triglyceride Elevation in Adult Women
por: Stefanska, Anna, et al.
Publicado: (2022)

Relationship between Serum Angiopoietin-like Proteins 3 and 8 and Atherogenic Lipid Biomarkers in Non-Diabetic Adults Depends on Gender and Obesity
por: Murawska, Karolina, et al.
Publicado: (2021)

Comparison of Apolipoprotein Concentrations and Values of APOB:APOAI with Traditional Lipid Measures in Women Diagnosed with Acute Cornonary Syndromes – A Preliminary Report
por: Krintus, Magdalena, et al.
Publicado: (2011)

Serum anti-Müllerian hormone as a predictive marker of polycystic ovarian syndrome
por: Parco, Sergio, et al.
Publicado: (2011)

Serum anti-Mullerian hormone predicts ovarian response in (Macaca fascicularis) monkeys
por: Long, Hui, et al.
Publicado: (2018)

Non-fasting lipid profile determination in presumably healthy children: Impact on the assessment of lipid abnormalities
por: Szternel, Lukasz, et al.
Publicado: (2018)

Association between Fasting Glucose Concentration, Lipid Profile and 25(OH)D Status in Children Aged 9–11
por: Szternel, Lukasz, et al.
Publicado: (2018)

Serum anti-Müllerian hormone levels as a predictor of the ovarian response and IVF outcomes
por: Choi, Min Hye, et al.
Publicado: (2011)

Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery
por: Kim, Hyun-Ah, et al.
Publicado: (2018)

Correlation of Serum Anti-Mullerian Hormone (AMH) Level on Ovarian Volume in Women with Endometrioma
por: Suardi, Dodi, et al.
Publicado: (2021)

Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency
por: Cai, Yan, et al.
Publicado: (2022)

New Biochemical Serum Markers of Boneturnover in Renal Osteodystrophy
por: Krintus, Magdalena, et al.
Publicado: (2004)

Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function
por: Moolhuijsen, Loes M E, et al.
Publicado: (2020)

Clinical application of serum anti-Müllerian hormone in women
por: Oh, So Ra, et al.
Publicado: (2019)

Impact of laparoscopic ovarian drilling on serum anti-mullerian hormone levels in patients with anovulatory Polycystic Ovarian syndrome
por: Paramu, Sobhana
Publicado: (2016)

Retracted: Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency
por: International, BioMed Research
Publicado: (2023)

Preoperative Serum Anti-Mullerian Hormone Level in Women with Ovarian Endometrioma and Mature Cystic Teratoma
por: Kim, Ju Yeong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1aevu7g0buhkbdkuehannfcekn